A Preliminary Comparative Assessment of the Role of CD8+ T Cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Multiple Sclerosis

Table 2

Clinical characteristics of CFS/ME and MS.

	CFS/ME (, mean ± SD)	MS (, mean ± SD)
Dr. Bell’s Disability	47.14% ± 2.20
Expanded Disability Status Scale		2.41 ± 0.79
Multiple Sclerosis Severity Scale		2.85 ± 0.89
Courses
(i) Relapsing-remitting
(ii) Secondary-progressive
(iii) Primary-progressive
(iv) Clinically isolated syndrome
Age of onset (years)	35.28 ± 4.63	6.11 ± 2.45
Duration (years)	14.96 ± 8.87	13.76 ± 3.83
Relapses rate		2.4 ± 0.55